Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pharmacokinetic Enhancer (PK Enhancer)
- Target
- PK Enhancer
- Molecular classification
- Enzyme inhibitor, Absorption enhancer
01
Overview
Pharmacokinetic enhancers are adjunctive agents designed specifically to optimize the exposure and efficacy profile of co-administered therapeutics by modulating their metabolism or absorption pathways. They play an essential role across several therapeutic areas but do not exert direct clinical effects themselves on underlying diseases.
- Other names
- BoosterBoosting AgentCYP3A Inhibitor (for those acting via this pathway)
02
Mechanism of action
Inhibition of drug-metabolizing enzymes (e.g., CYP3A4, DOPA decarboxylase, Beta-lactamases, Renal dehydropeptidase I) or enhancement of drug absorption, leading to increased plasma concentrations and prolonged activity of co-administered drugs.
03
Biological functions
Drug metabolism inhibitionIncreased drug bioavailability
04
Disease associations
HIV infectionBacterial infectionsParkinson's DiseaseCancer (indirectly, by enhancing kinase inhibitor exposure)
05
Safety considerations
Increased risk of adverse effects due to elevated drug exposurePotential for drug-drug interactions due to enzyme inhibitionLiver injury
06
Interacting drugs
Ritonavir
13 more in the full profile.
Beyond the preview
Go deeper on Pharmacokinetic Enhancer (PK Enhancer).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pharmacokinetic Enhancer (PK Enhancer).